Still Unconvinced?


Apparently I’m not the only one who thinks that Geron’s move to table its embryonic stem cell division is solely due to money. See comments by Daniel Salomon, associate professor in the department of molecular and experimental medicine at the Scripps Research Institute in San Diego in a story by ABC News.